open access

Vol 78, No 5 (2007)
ARTICLES
Get Citation

The safety and tolerance of isoflavones (SoyfemR) administration in postmenopausal women

Krzysztof Drews, Agnieszka Seremak-Mrozikiewicz, Ewa Puk, Agnieszka Kaluba-Skotarczak, Magdalena Malec, Agnieszka Kazikowska
Ginekol Pol 2007;78(5).

open access

Vol 78, No 5 (2007)
ARTICLES

Abstract

Introduction: In recent years, considerable attention has been paid to isoflavones and their proprieties to alleviate the climacteric symptoms. The goal of this study was to evaluate the efficacy of standardized isoflavones extract (SoyfemR) in moderate and medium-severe climacteric syndrome. Material and methods: 555 postmenopausal women were recruited for the study. Out of this group, 169 women completed the study (12- month observation period). The patients were classified according to the intensity of climacteric symptoms (≤34 points in Kupperman index). 1 or 2 tablets of SoyfemR were administered twice a day. Results: A regular decrease of Kupperman index value and improvement of life quality were observed in the group of 169 postmenopausal women. We have noted a decrease in the intensity and number of hot flushes, diaphoresis (p<0,05), diminished sleep disturbances (p<0,05), decreased headache, dizziness, and arthrosis pain. The diminished intensity of tiredness, palpitation and breathlessness have been also observed (p<0,05). 80% of all investigated women noted the regression of paresthesis, 20% indicated the decreased number of paresthesis (p<0,05). Influence of SoyfemR on the variability and moderation of depressive mood (p<0,05) have been also positive evaluated by patients. Conclusions: Administration of SoyfemR in the dosage 52 to 104mg/24 hours (2 times daily 1 or 2 tablets) is a safe and effective therapy in the postmenopausal women with moderate and medium-severe climacteric syndrome evaluated according to the Kupperman index. Administration of SoyfemR is connected with a good compliance and correlated with well-being in the investigated women allowing a long-term administration.

Abstract

Introduction: In recent years, considerable attention has been paid to isoflavones and their proprieties to alleviate the climacteric symptoms. The goal of this study was to evaluate the efficacy of standardized isoflavones extract (SoyfemR) in moderate and medium-severe climacteric syndrome. Material and methods: 555 postmenopausal women were recruited for the study. Out of this group, 169 women completed the study (12- month observation period). The patients were classified according to the intensity of climacteric symptoms (≤34 points in Kupperman index). 1 or 2 tablets of SoyfemR were administered twice a day. Results: A regular decrease of Kupperman index value and improvement of life quality were observed in the group of 169 postmenopausal women. We have noted a decrease in the intensity and number of hot flushes, diaphoresis (p<0,05), diminished sleep disturbances (p<0,05), decreased headache, dizziness, and arthrosis pain. The diminished intensity of tiredness, palpitation and breathlessness have been also observed (p<0,05). 80% of all investigated women noted the regression of paresthesis, 20% indicated the decreased number of paresthesis (p<0,05). Influence of SoyfemR on the variability and moderation of depressive mood (p<0,05) have been also positive evaluated by patients. Conclusions: Administration of SoyfemR in the dosage 52 to 104mg/24 hours (2 times daily 1 or 2 tablets) is a safe and effective therapy in the postmenopausal women with moderate and medium-severe climacteric syndrome evaluated according to the Kupperman index. Administration of SoyfemR is connected with a good compliance and correlated with well-being in the investigated women allowing a long-term administration.
Get Citation

Keywords

phytotherapy, izoflavones, menopause

About this article
Title

The safety and tolerance of isoflavones (SoyfemR) administration in postmenopausal women

Journal

Ginekologia Polska

Issue

Vol 78, No 5 (2007)

Bibliographic record

Ginekol Pol 2007;78(5).

Keywords

phytotherapy
izoflavones
menopause

Authors

Krzysztof Drews
Agnieszka Seremak-Mrozikiewicz
Ewa Puk
Agnieszka Kaluba-Skotarczak
Magdalena Malec
Agnieszka Kazikowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl